Obama budget calls for Medicare cuts for SNFs, penalizes rehospitalizations
Feb 14, 2012
While President Obama’s proposed 2013 budget contains expected Medicare cuts, long-term care groups have expressed their disappointment. Among other proposals, the American Health Care Association...
Talking up speech language pathology
By
John Andrews
Feb 01, 2012
Despite low profiles, speech professionals have assumed expanded roles and are making increasingly critical contributions to rehab regimens.
ReGear names Whitman to advisory board
Jan 25, 2012
Arnold Whitman has joined ReGear Life Sciences’ Board of Advisors, the therapy-device company announced. Whitman is founder and chairman of Formation Capital and co-chairman of Genesis HealthCare....
Omnicare extends PharMerica buy offer
By
John O'Connor
Jan 03, 2012
Pharmacy giant Omnicare announced that it was extending to Jan. 20 its offer to purchase all outstanding shares of rival PharMerica for $15 per share. The original offer had been scheduled to expire in...
Worms may reveal insights into wound healing response
By
John O'Connor
Jan 03, 2012
California researchers may have found an unlikely key to unlocking the secrets of wound healing in humans: the roundworm.
Quality care at hand
By
Julie Williamson
Jan 03, 2012
From tablets to smartphones, mobile technology is now an affordable way to spend more time with a resident while boosting efficiency for the caregiver.
Design decisions: Design as a matter of faith
By
Mary Gustafson
Dec 01, 2011
A new multi-faith chapel at one Florida continuing care retirement community provides enlightenment for believers and non-believers
Role of biomaterials is expected to grow
By
John O'Connor
Nov 01, 2011
Biomaterials likely will play a larger role in helping chronic wounds heal among diabetics, according to experts who spoke at the European Conference on Biomaterials in Dublin.
Genesis-Aetna alliance may preview ACO deals to come
By
Elizabeth Newman
Oct 01, 2011
A partnership between Genesis HealthCare and insurance giant Aetna is expected to drive down hospital readmission rates, provide better patient care and save both companies money.
FDA agrees to deal that speeds reviews
By
Matthew Arnold
Oct 01, 2011
The Food and Drug Administration and the biopharma industry have agreed in principle on a revamp of the Prescription Drug User Fee Act, by which drug firms provide nearly two-thirds of what the agency...